Continuing issues and debate concerning transnational commercial surrogacy during the COVID-19 pandemic and beyond
By Yuri Hibino, Sonia Allan, and Damian Adams,
BioNews
| 11. 30. 2020
The regulation of surrogacy varies around the world. Most countries that have laws, prohibit all forms of surrogacy, while several permit altruistic arrangements. A small number permit commercial surrogacy arrangements, and accept commissioning couples, or singles from nations where prohibitions exist. As a result, issues abound. For example, despite growing recognition that children have a right to information about their birth mother, gamete donor(s), and genetic siblings, transnational arrangements may provide little to no opportunity to build relationships when separated by language, culture, and/or location. Issues regarding the sale and commodification of children persist; cases of child abandonment are known. Trafficking of women across borders, bonded labour, health risks associated with surrogacy and egg donation, and ill-treatment of surrogates and intending mothers reported.
In 2020, COVID-19 also saw up to 1000 babies left in hospitals (or orphanages) in Russia, with intending parents unable to travel. In the Ukraine, babies were cared for in hotel rooms by nurses or nannies, or placed into public care (see BioNews 1048). Some surrogates struggled as they bonded with the baby or worried...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...